Clinical Trial Update: Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating colchicine in patients undergoing coronary artery bypass grafting after acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Reperfusion Injury
• Perioperative Myocardial Infarction
• Postpericardiotomy Syndrome

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Phase 2 | Status: COMPLETED